Results 181 to 190 of about 7,468 (210)
Some of the next articles are maybe not open access.

Cytometric monitoring of growth, sporogenesis and spore cell sorting in Paenibacillus polymyxa (formerly Bacillus polymyxa)

Journal of Applied Microbiology, 2002
Formation of bacterial endospores is a basic process in Gram-positive bacteria and has implications for health, industry and the environment. Flow cytometry offers a practical alternative for the rapid detection, enumeration and characterization of bacterial endospores.Paenibacillus polymyxa was chosen for this study because its spores cause sporangium
J, Comas-Riu, Josep, Vives-Rego
openaire   +2 more sources

Magnesium aminoclay-based transformation of Paenibacillus riograndensis and Paenibacillus polymyxa and development of tools for gene expression

Applied Microbiology and Biotechnology, 2016
Members of the genus Paenibacillus are widespread facultative anaerobic, endospore-forming bacteria. Some species such as Paenibacillus riograndensis or Paenibacillus polymyxa fix nitrogen and may play an important role in agriculture to reduce mineral nitrogen fertilization in particular for non-legume plants. The genetic manipulation of Paenibacillus
Fernandes de Brito, Luciana   +3 more
openaire   +3 more sources

Required characteristics of Paenibacillus polymyxa JB-0501 as potential probiotic

Archives of Microbiology, 2013
The ability of Paenibacillus polymyxa to inhibit the growth of Escherichia coli generic ATCC 25922 (Escherichia coli ATCC 25922) and to adhere to monolayers of the enterocyte-like human cell line Caco-2 was evaluated. P. polymyxa JB-0501 (P. polymyxa JB-0501), found in a livestock feed probiotic supplement, was compared to P.
Karim, Naghmouchi   +3 more
openaire   +2 more sources

CRISPR-Cas9-Mediated Genome Editing in Paenibacillus polymyxa

In recent years, the clustered regularly interspaced palindromic repeats-Cas (CRISPR-Cas) technology has become the method of choice for precision genome editing in many organisms due to its simplicity and efficacy. Multiplex genome editing, point mutations, and large genomic modifications are attractive features of the CRISPR-Cas9 system.
Giulia, Ravagnan   +2 more
openaire   +2 more sources

Calcium removal from bauxite using Paenibacillus polymyxa

Mining, Metallurgy & Exploration, 1999
The biological removal of calcium SI-om a bauxite ore in the presence of the soil bacterium Paenibacillus polymyxa is demonstrated. A column bioreactor that call be either-operated in a fluidized-bed (FB) mode for coarser particles or in a total-recycle-slurry (TRS) mode for finer particles was designed fabricated and rested for this purpose.
Modak, JM, Vasan, SS, Natarajan, KA
openaire   +1 more source

Enhanced 2,3-Butanediol Production by Addition of Acetic Acid in Paenibacillus polymyxa.

Journal of Bioscience and Bioengineering, 2000
By the addition of 150 mM acetate into a batch culture at an initial pH of 6.8, the production of 2,3-butanediol (BDL) by Paenibacillus polymyxa reached 248 mM, yielding 0.87 mol.mol(-1) glucose, where the ratio of acetate consumed to glucose consumed (A/C ratio) was calculated as 0.35 mol acetate mol(-1) glucose.
Y, Nakashimada   +4 more
openaire   +2 more sources

Structure and characterization of an extracellular polysaccharide from Paenibacillus polymyxa 88A

International Journal of Biological Macromolecules
Levan-type polysaccharides, produced by various organisms, are nontoxic, biocompatible, and biodegradable polymers with a wide range of biological activities. They have high potential for use in medicine, cosmetology, and industry. A large amount of levan (41.1 g L-1) was recovered by ethanol precipitation from a liquid nutrient medium of Paenibacillus
Vyacheslav S, Grinev   +8 more
openaire   +2 more sources

Metabolic engineering of “last-line antibiotic” colistin in Paenibacillus polymyxa

Metabolic Engineering
Colistin, also known as polymyxin E, is a lipopeptide antibiotic used to treat infections caused by multidrug-resistant gram-negative bacteria. It is considered a "last-line antibiotic", but its clinical development is hindered by low titer and impurities resulting from the presence of diverse homologs in microbial fermentation.
Nanzhu Chen   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy